Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GL Biochem
Shanghai, Shanghai, Chinaglschina.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
GL Biochem operates at commercial scale as one of the world’s largest custom peptide manufacturers. They do not have their own clinical pipeline but support global R&D with high-quality peptides and antibodies. Their products are used in preclinical through commercial applications by clients worldwide
- Therapeutic areas
- Other
- Modalities
- PeptidesAntibodySmall moleculeAmino acids and derivatives
- Industry
- Contract Manufacturing Organization
02
Partnerships
Not specifically listed; serves major pharmaceutical companies, biotech firms, universities globally
Beyond the preview
Go deeper on GL Biochem.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GL Biochem.